Venus Vila GLB system VI102402GLBRecalls & reported problems
Venus Concept Ltd · Class 2
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07290016541052), received between Dec 19, 2025 and Dec 19, 2025 — classified as 1 injury.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Swelling/ Edema1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryDec 19, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
INVESTIGATION ANALYSIS: VENUS CONCEPT WAS NOTIFIED ON 11/28/2025 OF MEDICAL DEVICE REPORT (MDR) - MW5178619 DATE OF THIS REPORT: 03-NOV-2025 MDR WAS SUBMITTED TO THE FDA. EVENT DESCRIPTION: ON 31-OCT-2025 - "I WAS SUBMITTED TO TREATMENT USING VENUS VIVA RF EQUIPMENT. THE NEXT DAY, I WOKE UP WITH MODERATE FACIAL SWELLING, ESPECIALLY IN THE CHEEK AREA. ON THE SECOND DAY, MY EYES AND THE AREA AROUND MY MOUTH BECAME SWOLLEN. I HAD TO SEEK MEDICAL ATTENTION BECAUSE I WAS AFRAID IT MIGHT AFFECT MY BREATHING. THIS WAS MY FIRST SESSION." LABELING: PER VENUS VIVA USER MANUAL, UMVIGLB REV L A.6.3. EXPECTED CLINICAL EFFECTS AND POSSIBLE SIDE EFFECTS DURING OR IMMEDIATELY AFTER THE TREATMENT, CERTAIN EFFECTS AND RESPONSES MAY OCCUR. ALTHOUGH THESE EFFECTS ARE EXPECTED AND TRANSIENT, ANY ADVERSE REACTION SHOULD BE IMMEDIATELY REPORTED TO THE PHYSICIAN. SIDE EFFECTS MAY APPEAR EITHER AT THE TIME OF THE TREATMENT OR AFTER IT. EXPECTED CLINICAL EFFECTS AND POSSIBLE SIDE EFFECTS MAY INCLUDE: TRANSIENT EXCESSIVE SKIN REDNESS (ERYTHEMA) AND/OR SWELLING (EDEMA) MAY OCCUR. B.8. TEST TREATMENT CAUTION: IN ORDER TO PREVENT ADVERSE EFFECTS, TEST SPOTS SHOULD BE PERFORMED BEFORE EACH TREATMENT AND UPON CHA
Patient problems: Swelling/ Edema
MAUDE report 23849037 ↗
Other Electrosurgical, Cutting & Coagulation & Accessories devices
- Vasoview Hemopro 2 VH-4000Maquet Cardiovascular LLC · Electrosurgical, Cutting & Coagulation & Accessories6 recalls1 death3,232 reports
- LigaSure LF1937Covidien LP · Electrosurgical, cutting & coagulation & accessories3 deaths2,090 reports
- Olympus WB91051WOLYMPUS Winter & Ibe GmbH · Electrosurgical, Cutting & Coagulation & Accessories1 death1,951 reports
- Valleylab FT10 VLFT10GENCovidien LP · Electrosurgical, cutting & coagulation & accessories1 recall5 deaths1,062 reports
- LigaSure LF1837Covidien LP · ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES1 recall967 reports
- LigaSure LF2019Covidien LP · Electrosurgical, cutting & coagulation & accessories948 reports
- VAPR 225028Depuy Mitek, LLC · ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES895 reports
- LigaSure LF1923Covidien LP · Electrosurgical, cutting & coagulation & accessories855 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page